NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 17th Annual BIO CEO & Investor Conference in New York City.
Help employers find you! Check out all the jobs and post your resume.
